发明授权
- 专利标题： Use of interleukin-1 (IL-1) to inhibit development of hepatitis
- 专利标题（中）： 使用白介素-1（IL-1）抑制肝炎的发展
-
申请号： US139862申请日： 1993-10-22
-
公开(公告)号： US5723117A公开(公告)日： 1998-03-03
- 发明人: Satoru Nakai , Seiji Akamatsu , Yoshihiro Masui , Tsutomu Nishida , Takashi Kamogashira , Yoshikatu Hirai
- 申请人： Satoru Nakai , Seiji Akamatsu , Yoshihiro Masui , Tsutomu Nishida , Takashi Kamogashira , Yoshikatu Hirai
- 申请人地址： JPX Tokyo
- 专利权人： Otsuka Pharmaceutical Co., Ltd.
- 当前专利权人： Otsuka Pharmaceutical Co., Ltd.
- 当前专利权人地址： JPX Tokyo
- 优先权： JPX2-212941 19900810
- 主分类号： A61K38/00
- IPC分类号： A61K38/00 ; C07K14/545 ; A61K38/20
摘要：
A drug for preventing and curing liver diseases comprising at least one member selected from interleukin-1 and its derivatives as an effective component. The drug meaningfully suppresses GOT and GPT activities in blood which are markers of liver diseases, and also suppresses symptoms such as choloplania.
公开/授权文献
信息查询
IPC分类:
